CSHL Stories and Media archive for Tag: cancer research

Copper, cancer, and COVID-19: The story of an idea, a meeting, and a paper

3/4/2022

The Copper Cancer Consortium started as a new treatment concept and is now a published paper. Read the story of Banbury's last meeting before COVID. Read the story »

Don Monti Memorial Research Foundation gives $100,000

1/26/2022

Don Monti Memorial Research Foundation has donated $100,000 to CSHL’s cancer genetics research program. Read the story »

The Darlene Carbone Brain Tumor Foundation donates $25,000 to CSHL

1/24/2022

The Darlene Carbone Brain Tumor Foundation donates $25,000 to Dr. Alea Mills lab for glioblastoma research. Read the story »

$3 Million gift from longtime benefactor Edith Seligson

1/20/2022

CSHL announces a $3 million gift from longtime benefactor Edith Seligson to name the Alan and Edith Seligson Professor of Cancer Research. Read the story »

Obscure protein is spotlighted in fight against leukemia

1/11/2022

CSHL scientists find that a protein previously unknown to cancer researchers may hold the key to targeting acute myeloid leukemia. Read the story »

Corina Amor joins CSHL faculty

1/7/2022

Corina Amor is the newest fellow at CSHL. She studies immunology and aging. Read the story »

Three Strohm Sisters Family Foundation donates $20,000 to CSHL

12/16/2021

The Three Strohm Sisters Family Foundation donated $20,000 for cancer research at Cold Spring Harbor Laboratory. Read the story »

In breast cancer, the best defense is a strong offense

12/7/2021

CSHL cancer researchers revealed how the immune system prepares to combat breast cells that may turn cancerous after a pregnancy. Read the story »

Exploiting cancer’s sweet tooth

10/25/2021

Sugar addiction is a weakness for cancer cells, especially if they have only one method to get what they need. Read the story »

CSHL receives 2021 NCI grant of $4.5 million

10/1/2021

The National Cancer Institute renewed its Basic Laboratory Cancer Center grant for CSHL, marking 34 years of our continued progress in cancer research. Read the story »

Mestag, co-founded by CSHL prof, named leading new biotech

9/27/2021

Fierce Biotech named Mestag Therapeutics, co-founded by CSHL Professor David Tuveson, a 2021 “Fierce 15” leader in the biotech and pharma business. Read the story »

Frontiers of cancer research quiz

Test your knowledge of the newest developments in cancer research with some science trivia. Take the quiz »

Immune cells versus metastatic tumor cells

9/2/2021

Macrophages help the immune system defend the body from bacteria. They can be reprogrammed to destroy cancer cells. Watch the video »

When cancer cells “put all their eggs in one basket”

5/27/2021

CSHL researchers uncover a weakness in acute myeloid leukemia cells that can be targeted by cancer drugs. Read the story »

$11 million investment to develop fibroblast therapeutic

4/26/2021

CSHL Professor David Tuveson and other leading disease experts founded a company to target fibroblasts as a new way to treat cancer and inflammatory diseases. Read the story »